en
Scientific article
English

Guidance to develop individual dose recommendations for patients on chronic hemodialysis

Published inExpert Review of Clinical Pharmacology, vol. 10, no. 7, p. 737-752
Publication date2017
Abstract

In addition to tailored clinical trials in patients on chronic hemodialysis (HD) during drug development, clinician-initiated post-marketing studies and case reports on individual pharmacokinetic (PK) assessments provide an important source of information about drug dialysability and individualized dose recommendations in this vulnerable population. Areas covered: First, factors that may alter drug exposure in HD patients are explained. Second, available regulatory and methodological guidelines for PK assessments in this population are summarized. Third, a 4-step approach is proposed to develop individual dose recommendations for HD patients receiving drugs without data from a PK study: (1) literature search, (2) model-based dosage decisions, (3) validation and refinement through concentration monitoring, and (4) publication of relevant observations. Fourth, clinician-initiated PK assessments and case reports to evaluate and individualize use of drugs in HD patients are reviewed, and recommendations to enhance their quality are discussed. Expert commentary: Guidance on collecting and reporting PK information in individual HD patients is warranted to ensure completeness and consistency of such PK studies. A checklist and template for easy-to-implement PK calculations and pharmacometric modeling is provided to facilitate evaluation and individualization of dosing strategies in these patients.

Keywords
  • Checklist
  • Dose-Response Relationship
  • Drug
  • Drug Design
  • Humans
  • Models
  • Biological
  • Pharmaceutical Preparations/administration & dosage/metabolism
  • Pharmacokinetics
  • Practice Guidelines as Topic
  • Renal Dialysis
Citation (ISO format)
GOTTA, Verena et al. Guidance to develop individual dose recommendations for patients on chronic hemodialysis. In: Expert Review of Clinical Pharmacology, 2017, vol. 10, n° 7, p. 737–752. doi: 10.1080/17512433.2017.1323632
Identifiers
ISSN of the journal1751-2433
442views
0downloads

Technical informations

Creation10/25/2017 10:15:00 AM
First validation10/25/2017 10:15:00 AM
Update time03/15/2023 2:30:07 AM
Status update03/15/2023 2:30:07 AM
Last indexation01/17/2024 1:37:19 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack